Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy

[Image: see text] The tumor microenvironment (TME) plays a significant role in weakening the effect of cancer immunotherapy, which calls for the remodeling of TME. Herein, we fabricated a nanostructured lipid carrier (NLC) to codeliver doxorubicin (Dox) and sorafenib (Sfn) as a drug delivery system...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jia-Yang, Song, Ya-Qi, Peng, Jing, Luo, Hong-Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495447/
https://www.ncbi.nlm.nih.gov/pubmed/32954132
http://dx.doi.org/10.1021/acsomega.0c02072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495447/
https://www.ncbi.nlm.nih.gov/pubmed/32954132
http://dx.doi.org/10.1021/acsomega.0c02072

Ejemplares similares